Trials / Conditions / Acute Optic Neuritis
Acute Optic Neuritis
3 registered clinical trials studyying Acute Optic Neuritis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing NCT02833142 | Biogen | Phase 1 |
| Completed | Long-Term Assessment of Remyelinating Therapy NCT02657915 | Biogen | Phase 2 |
| Completed | BIIB033 In Acute Optic Neuritis (AON) NCT01721161 | Biogen | Phase 2 |